Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Mater Sci Eng C Mater Biol Appl ; 96: 51-57, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30606561

ABSTRACT

Core-shell Fe3O4/Au nanostructures were constructed using an advanced method of two-step synthesis from Juglans regia (walnut) green husk extract. Several complementary methods were applied to investigate structural and magnetic properties of the samples. X-ray diffraction (XRD), high-resolution transmission electron microscopy (HR-TEM), electron diffraction, optical, thermogravimetric analysis (TGA), and vibrating sample magnetometer (VSM) were used for nanoparticle characterizations. As shown by HR-TEM, the mean diameter of core-shell Fe3O4/Au nanoparticles synthesized using co-precipitation method was 6.08 ±â€¯1.06 nm. This study shows that the physical and structural properties of core-shell Fe3O4/Au nanoparticles possess intrinsic properties of gold and magnetite. VSM revealed that the core-shell Fe3O4/Au have high saturation magnetization and low coercivity due to the magnetic properties. The core-shell nanoparticles show the inhibitory concentration (IC)50 of 235 µg/ml against a colorectal cancer cell line, HT-29. When tested against non-cancer cells, IC50 was not achieved even up to 500 µg/ml. This study highlights the magnetic properties and anticancer action of core-shell Fe3O4/Au nanoparticles. This compound can be ideal candidate for cancer treatment and other biomedical applications.


Subject(s)
Antineoplastic Agents , Colorectal Neoplasms/drug therapy , Ferrosoferric Oxide , Gold , Nanoparticles , Animals , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Ferrosoferric Oxide/chemical synthesis , Ferrosoferric Oxide/chemistry , Ferrosoferric Oxide/pharmacology , Gold/chemistry , Gold/pharmacology , HT29 Cells , Humans , Juglans/chemistry , Mice , NIH 3T3 Cells , Nanoparticles/chemistry , Nanoparticles/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL